The difference between pharmaceutical and biotechnology

While sitting in a meeting recently I was asked, 'what exactly is the difference between pharma and biopharma?'

For most of us, we may not necessarily know the difference between both, so here is a basic description of the differences between the two industries which have made Ireland their home in the last number of years:

PharmaceuticalWorking with plant and chemical based compounds, pharmaceutical companies work their magic to make medicines that cure or manage diseases, and protect us from infection. Pharmaceuticals include a handful of major companies that dominate the industry. While many of these firms also produce animal health products, livestock feed supplements, vitamins and a host of other goods, this profile will focus solely on their drug products used to treat human illness.

Depending on their size and strategy, pharmaceutical companies may conduct extensive research in-house or they may seek to license promising drugs from academia, other pharmaceuticals, or biotechnology companies. The latter firms are generally smaller than their Big Pharma competitors, and they employ cellular and bimolecular processes to make medicines or diagnose illness.

BiotechnologyBiotechnology is the applied knowledge of biology, it seeks to duplicate or change the function of a living cell so it will work in a more predictable and controllable way. The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions. Several biotech companies also use genetic technology to other ends, like the manipulation of crops. Biopharmaceuticals hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease. Biopharmaceuticals are therapeutic agents intended to treat symptoms and/or underlying causes of a variety of disorders and diseases.

The primary difference between biopharmaceuticals and traditional pharmaceuticals is the method by which the drugs are produced: The former are manufactured in living organisms such as bacteria, yeast and mammalian cells, whereas the latter are manufactured through a series of chemical synthesis.

Biopharmaceuticals are primarily developed in both academic and industrial laboratories. The commercialisation process is often funded by venture capital firms (for academic and start-ups) or drug companies. Prior to sale, drugs are assessed by the Food & Drug Administration (FDA) and other international regulatory agencies for safety and efficacy.

Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they are still developing their initial products. Biotech firms tend to expand their marketing and sales forces when, and if a viable product nears FDA approval. Biotech companies tend to be located in geographical clusters, often near prominent research universities. The largest concentration of biotech companies in Ireland are in Cork and Dublin as these areas have made an effort to focus on drawing biotech companies by devoting to finding resources for them.

Those who choose to work in this industry enjoy the very real satisfaction of knowing that they are working to produce drugs that could make a radical difference in the lives of thousands, even millions, of people.

Featured Posts
Recent Posts
Archive
Search By Tags

About Pharmanaming.com and GNN

The Global Naming Network (GNN), headquartered in Geneva, is the world's largest network of independent naming and brand identity agencies.

 

With around 240 cooperating naming and branding specialists in 16  countries, from Beijing to New York and from Seoul to Paris, GNN works for clients ranging from large multinationals to small startups all over the world.

Pharmaceutical projects are coordinated from the GNN office in Amsterdam by the pharma naming specialists of Globrands.

The www.pharmanaming.com website is dedicated to our expertise and work for the health & pharma industry.

 

Please contact us for more information.

20

offices in 16 countries

240

creatives, strategists & consultants

GNN offices

China                     South Korea

France                   Italy
Germany               Japan

Netherlands          UK

India                      Singapore

Spain                     Canada

Switzerland          Russia

USA                       Dubai

5000

projects successfully executed

Pages

home                           name to brand

health & pharma        people

regulatory                   test & submit

India                             FDA

work                             blog

clients                          contact

20000

linguistic professionals worldwide

Globrands the name behind the brands

© 2020 by Globrands consultancy group

Herengracht 122, 1015 BT Amsterdam, the Netherlands

call +31206238555 or mail to pharma@globrands.com  

 

  • White LinkedIn Icon